Randomised double-blind active-placebo-controlled crossover trial of intravenous fentanyl in neuropathic pain

Lancet

Volumn 349, Issue 9054, 1997, Pages 753-758

  Dellemijn, Paul L I ^a,b   Vanneste, Jan A L ^a  

^a ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

^b ST JOSEPH HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; DIAZEPAM; FENTANYL; OPIATE; SODIUM CHLORIDE;

ADULT; AGED; ANALGESIA; ARTICLE; BREATHING DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FEMALE; HICCUP; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; NAUSEA; NEUROPATHY; PAIN; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SEDATION; VERTIGO; VISUAL DISORDER; VOMITING; XEROSTOMIA;

EID: 0030945973     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)09024-1     Document Type: Article

References (30)

1. Merskey H, Lindblom U, Mumford JM, Nathan PW, Sunderland S. Pain terms: a current list with definitions and notes of usage. In: Merskey H, Bogduk N, eds. Classification of chronic pain, 2nd edn. Seatle: IASP Press, 1994: 207-13.
2. Portenoy RK. Neuropathic pain. In: Portenoy RK, Kanner RM, eds. Pain management: theory and practice. Philadelphia: FA Davis Company, 1996: 83-125.
3. Arnér S, Meyerson BA. Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain. Pain 1988; 33: 11-23.
4. Portenoy RK, Foley KM, Inturrisi CE. The nature of opioid responsiveness and its implications for neuropathic pain: new hypotheses derived from studies of opioid infusions. Pain 1990; 43: 273-86.
5. Urban BJ, France RD, Steinberger EK, Scott DL, Maltbie AA. Long-term use of narcotic/antidepressant medication in the management of phantom limb pain. Pain 1986; 24: 191-96.
6. Rowbotham MC, Reisner-Keller LA, Fields HL. Both intravenous lidocaine and morphine reduce the pain of post-herpetic neuralgia. Neurology 1991; 41: 1024-28.
7. Kupers RC, Konings H, Adriaensen H, Gybels JM. Morphine differentially affects the sensory and affective pain ratings in neurogenic and idiopathic forms of pain. Pain 1991; 47: 5-12.
8. Jadad AR, Carroll D, Glynn CJ, Moore RA, McQuay HJ. Morphine responsiveness of chronic pain: double-blind randomised crossover study with patient-controlled analgesia. Lancet 1992; 339: 1367-71.
9. McQuay HJ, Jadad AR, Carroll D, et al. Opioid sensitivity of chronic pain: a patient-controlled analgesia method. Anaesthesia 1992; 47: 757-67.
10. Dellemijn PLI, Verbiest HBC, van Vliet JJ, Roos PJ, Vecht CJ. Medical therapy of malignant nerve pain: a double-blind explanatory trial with naproxen and slow-release morphine. Eur J Cancer 1994; 30: 1244-50.
11. Max MB, Schafer SC, Culnane M, Dubner R, Gracely RH. Association of pain relief with drug side effects in postherrpetic neuralgia: a single-dose study of clonidine, codeine, ibuprofen and placebo. Clin Pharmacol Ther 1988; 43: 363-71.
12. Asbury AK, Fields HL. Pain due to peripheral nerve damage: a hypothesis. Neurology 1984; 34: 1587-90.
13. Tasker RR. Deafferentation pain syndromes: introduction. In: Nashold BS, Ovelman-Levit J, eds. Deafferentation pain syndromes: pathophysiology and treatment. New York: Raven Press, 1991: 241-57.
14. Hromada J. On the nerve supply of connective tissue of some peripheral nervous system components. Acta Anat 1963; 55; 343-51.
15. Appenzeller O, Dhital KK, Cowen T, Burnstock G. The nerves to blood vessels supplying to blood nerves: the innervation of vasa nervorum. Brain Res 1984; 304: 383-86.
16. Zochodne DW. Epineurial peptides: a role in neuropathic pain? Can J Neurol Sci 1993; 20: 69-72.
17. Devor M, White DM, Goetz EJ, Levine JD. Eicosanoids, but not tachykinins, excite C-fiber endings in rat sciatic nerve-end neuromas. Neuroreport 1992; 3: 21-24.
18. Devor M, Basbaum AI, Bennet GJ. Group report: mechanisms of neuropathic pain following peripheral injury. In: Basbaum AI, Besson J-M, eds. Towards a new pharmacotherapy of pain. New York: Wiley, 1991: 417-40.
19. Price DD, Von der Gruen A, Miller J, Rafii A, Price C. A psychophysical analysis of morphine analgesia. Pain 1985; 22: 261-69.
20. Poklis A. Fentanyl: a review for clinical and analytical toxicologists. Clin Toxicol 1995; 33: 439-47.
21. Dellemijn PLI, Fields HL, Allen RR, McKay WR, Rowbotham MC. The interpretation of pain relief and sensory changes following sympathetic blockade. Brain 1994; 117; 1475-87.
22. Zung WWK. A self-rating depression scale. Arch Gen Psychiatry 1965; 12: 63-70.
23. Koch GG. The use of non-parametric methods in the statistical analysis of the two-period cross-over design. Biometrics 1972; 28: 577-84.
24. Price DD, Harkins SW, Rafii A, Price C. A simultaneous comparison of fentanyl's analgesic effects on experimental and clinical pain. Pain 1986; 24: 197-203.
25. Chapman CR, Feather BW. Effect of diazepam on human pain tolerance and pain sensitivity. Psychosom Med 1973; 35: 330-40.
26. Gracely RH, Dubner R, McGrath P. Fentanyl reduces the intensity of painful toothpulp sensations: controlling for detection of active drugs. Anesth Analg 1982; 61: 751-55.
27. Gracely RH, McGrath P, Dubner R. Validity and sensitivity of ratio scales of sensory and affective verbal pain descriptors: manipulation of affect by diazepam. Pain 1978; 5: 19-29.
28. Dellemijn PLI, Fields HL. Do benzodiazepines have a role in chronic pain management? Pain 1994; 57: 137-52.
29. McClain DA, Hug CC Jr. Intravenous fentanyl kinetics. Clin Pharmacol Ther 1980; 28: 106-14.
30. Moulin DE, lezzi A, Amireh R, Sharpe WKJ, Boyd D, Merskey H. Randomised trial of oral morphine for chronic non-cancer pain. Lancet 1996; 347: 143-47.